Jiang Y, et al. - Researchers compared the diagnostic accuracy and interpretation time of screening automated breast ultrasound (ABUS) for women with dense breast tissue without and with use of a recently U.S. Food and Drug Administration–approved computer-aided detection (CAD) system for concurrent read. Eighteen radiologists interpreted a cancer-enriched set (ie, cancer prevalence higher than in the original screening cohort) of 185 screening ABUS studies (52 with and 133 without breast cancer) in a retrospective observer performance study. Among women with dense breast tissue who do not have symptoms, use of the concurrent-read CAD system for interpretation of screening ABUS studies could make interpretation significantly faster and produce noninferior diagnostic accuracy compared with interpretation without the CAD system.